TA
ZBH icon

Tiedemann Advisors’s Zimmer Biomet ZBH Stock Holding History

Tiedemann Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,419
Closed -$214K – 349
2020
Q4 		$214K Sell
1,419
-263
-16% -$37.1K 0.01% 294
2020
Q3 		$224K Buy
+1,682
New +$220K 0.01% 293
2020
Q1 		– Sell
-1,812
Closed -$263K – 330
2019
Q4 		$263K Buy
+1,812
New +$250K 0.01% 261

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Tiedemann Advisors's ZBH Position: Q1 2021 in Review

Tiedemann Advisors sold out of Zimmer Biomet (ZBH) in Q1 2021, closing a stake of 1,419 shares — an estimated $214K sold.

Tiedemann Advisors first reported a position in ZBH in Q4 2019 and held it in 3 quarters. The position peaked at $263K in Q4 2019. 1,029 funds tracked by Wall St. Rank hold ZBH as of Q1 2021.

  • Tiedemann Advisors reported no remaining Zimmer Biomet position as of Q1 2021 after selling out during the quarter.
  • Tiedemann Advisors sold 1,419 Zimmer Biomet shares in Q1 2021, an estimated $214K.
  • Tiedemann Advisors first reported a position in Zimmer Biomet in Q4 2019 and held it in 3 quarters.
  • Tiedemann Advisors's Zimmer Biomet position peaked at $263K in Q4 2019.
  • 1,029 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2021.

Based on Tiedemann Advisors's 13F filing for Q1 2021, filed 13 May 2021.